NuVasive, Inc.
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 19, 2008
NUVASIVE, INC.
(Exact name of registrant as specified in its charter)
         
Delaware   000-50744   33-0768598
         
(State or Other Jurisdiction of
Incorporation) 		  (Commission File
Number) 		  (I.R.S. Employer Idenitifcaiton
Number)
4545 Towne Centre Court, San Diego, California 92121
(Address of principal executive offices, with zip code)
(858) 909-1800
(Registrant’s telephone number, including area code)
n/a
(Former name or former address, if changed since last report)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 2.02 Results of Operations and Financial Condition
Item 9.01 Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1

Table of Contents

Item 2.02 Results of Operations and Financial Condition
On February 19, 2008, NuVasive, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2007. A copy of this press release is furnished as Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1   Press release issued by NuVasive, Inc. on February 19, 2008, announcing financial results for the quarter and year ended December 31, 2007.

-2-

Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  NUVASIVE, INC.
 		  
Date: February 19, 2008  By:   /s/ Alexis V. Lukianov    
    Alexis V. Lukianov   
    Chairman and Chief Executive Officer   
 

-3-

Table of Contents

EXHIBIT INDEX
         
Exhibit    
Number   Description of Document
99.1      
Press release issued by NuVasive, Inc. on February 19, 2008, announcing financial results for the quarter and year ended December 31, 2007.

-4-